Skip to main content

  • Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis

    • Posted: 07/15/2020
    • Author:

      Jose M. de la Torre Hernández, Tamara Garcia Camarero, Fernando Lozano Ruiz-Poveda, Cristóbal A. Urbano-Carrillo, ... Javier Zueco

    • 2020CRM

    Highlights

    • In the European guidelines on myocardial revascularization 2018 DCB are recommended for the treatment of ISR under a class IA.
    • There is no class effect for DCB, so every new DCB design has to be evaluated by means of preclinical and clinical studies.
    • In this study, the ESSENTIAL DCB showed a good and sustained efficacy in prevention of recurrent ISR in terms of QCA and OCT derived endpoints.
    • The ESSENTIAL DCB seems to perform comparably to the most evidence-supported DCB.

    Abstract

    Objectives

    This study sought to assess the efficacy of the drug-coated balloon (DCB) ESSENTIAL for the treatment of in-stent restenosis (ISR).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details